Does the public record back up what this life-sciences deck says?

A biotech deck makes claims an investor can check: which trial phase the lead asset is in, which designations it holds, how much grant money it has won, which patents it holds, and whether a university still holds a stake. Those records are public but spread across registers in three jurisdictions. Type a name, choose the company, and read them in one place.

An automated first look. It reports what the registers show and never judges the science. Trials run by partners, grants held by a university and assets licensed in all look like absence from here, so the strongest thing it says is "check this". To put a number on one drug, use the drug asset calculator.

Not legal, investment or scientific advice. It reads organisation records only and names no individuals. Sources: ClinicalTrials.gov, the EU Clinical Trials Information System, Drugs@FDA (openFDA), the FDA's orphan-drug designations, UKRI's Gateway to Research (Open Government Licence), the EPO's worldwide patent data (Open Patent Services) and Companies House. Registers lag the events they record; UKRI's grant data can run months behind.